search button

Bak Foong pills combined with metformin in the treatment of a polycystic ovarian syndrome rat model

  • Authors:
    • Wenhui Liu
    • Wenpei Liu
    • Yuling Fu
    • Yan Wang
    • Yuanzhen Zhang

  • View Affiliations

  • Published online on: July 8, 2015     https://doi.org/10.3892/ol.2015.3466
  • Pages: 1819-1825
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of the present study was to investigate the treatment effects and associated mechanism of Bak Foong pills (BFPs) combined with metformin in the treatment of polycystic ovarian syndrome (PCOS). BFPs and/or metformin were administrated to treat the PCOS rats, and the weights and morphologies of the ovary, uterus and adrenal gland were measured. The levels of fasting blood glucose (FBG), serum testosterone (T), luteinizing hormone, fasting insulin (FIN) and insulin‑like growth factor‑1 were also measured, and the homeostasis model assessment of insulin resistance (HOMA‑IR) was calculated. The expression level of androgen receptor (AR) in the ovarian tissue, and the cytochrome P450 cholesterol side‑chain cleavage enzyme (P450scc) mRNA levels in the ovary and adrenal tissues were detected. The levels of T, FIN, FBG and HOMA‑IR in the combination group were significantly reduced; the wet weights of the ovary and the adrenal gland were decreased significantly, while that of the uterus was increased, and the histological morphology benignly recovered. The rats of each treatment group all experienced restored ovulation. The AR expression level in the treatment group was reduced, and the P450scc mRNA levels in the ovary and the adrenal gland of the combined treatment group were decreased. BFPs combined with metformin significantly affected PCOS, and the possible mechanism involved in the treatment may have been through the reduction of P450scc generation. BFPs may reduce the androgen levels, thus allowing the ovary to restore ovulation.
View References

Related Articles

Journal Cover

September-2015
Volume 10 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.5
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 5.7
  • CiteScore Rank: Q2: #139/404 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.574
  • SCImago Journal Rank (SJR): 0.644
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Liu W, Liu W, Fu Y, Wang Y and Zhang Y: Bak Foong pills combined with metformin in the treatment of a polycystic ovarian syndrome rat model. Oncol Lett 10: 1819-1825, 2015.
APA
Liu, W., Liu, W., Fu, Y., Wang, Y., & Zhang, Y. (2015). Bak Foong pills combined with metformin in the treatment of a polycystic ovarian syndrome rat model. Oncology Letters, 10, 1819-1825. https://doi.org/10.3892/ol.2015.3466
MLA
Liu, W., Liu, W., Fu, Y., Wang, Y., Zhang, Y."Bak Foong pills combined with metformin in the treatment of a polycystic ovarian syndrome rat model". Oncology Letters 10.3 (2015): 1819-1825.
Chicago
Liu, W., Liu, W., Fu, Y., Wang, Y., Zhang, Y."Bak Foong pills combined with metformin in the treatment of a polycystic ovarian syndrome rat model". Oncology Letters 10, no. 3 (2015): 1819-1825. https://doi.org/10.3892/ol.2015.3466